Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
Flaminia Olearo, Huyen Nguyen, Fabrice Bonnet, Sabine Yerly, Gilles Wandeler, Marcel Stoeckle, Matthias Cavassini, Alexandra Scherrer, Dominique Costagliola, Patrick Schmid, Huldrych F Günthard, Enos Bernasconi, Jürg Boeni, Antonella D'arminio Monforte, Maurizio Zazzi, Barbara Rossetti, Didier Neau, Pantxika Bellecave, Bart Rijnders, Peter Reiss, Ferdinand Wit, Roger Kouyos & Alexandra Calmy
abstract
|
[This corrects the article DOI: 10.1093/ofid/ofz330.][This corrects
the article DOI: 10.1093/ofid/ofz330.].
|
|
|
citation
|
Olearo F, Nguyen H, Bonnet F, Yerly S, Wandeler G, Stoeckle M,
Cavassini M, Scherrer A, Costagliola D, Schmid P, Günthard H F,
Bernasconi E, Boeni J, D'arminio Monforte A, Zazzi M, Rossetti B,
Neau D, Bellecave P, Rijnders B, Reiss P, Wit F, Kouyos R, Calmy A.
Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of
Abacavir/Lamivudine/Dolutegravir Therapy in HIV
Treatment-Experienced Patients. Open Forum Infect Dis 2019;
6:ofz500.
|
|
|
type
|
journal paper/review (English)
|
date of publishing
|
08-12-2019
|
journal title
|
Open Forum Infect Dis (6/12)
|
ISSN print
|
2328-8957
|
pages
|
ofz500
|
PubMed
|
31832485
|
DOI
|
10.1093/ofid/ofz500
|
additional links & downloads